On November 2nd 2023, the JDRF Centre of Excellence at UBC held its second annual meeting to review research progress, celebrate advances, brainstorm challenges, map out next steps, and exchange knowledge about the lived experience of T1D – all with a view to accelerate the path towards a cure for T1D via the Centre’s research […]
New Trial Shows Benefits of Hybrid Closed Loop in Pregnancy
A JDRF UK-supported trial published in the New England Journal of Medicine and presented at the 2023 European Association for the Study of Diabetes conference demonstrated that hybrid closed loop technology helps pregnant individuals better manage their blood glucose compared to traditional insulin pumps or multiple daily injections. Authors say that hybrid closed-loop technology […]
New results from a clinical trial of once-weekly insulin
We are getting closer to the possibility of people with type 1 diabetes (T1D) needing to administer basal insulin only once a week instead of every single day, with Novo Nordisk announcing the latest results of its ONWARDS 6 clinical trial. What was the clinical trial studying? ONWARDS clinical trials, which have been ongoing for the […]
JDRF is deeply saddened by the loss of one of its founding family members, Susan Gold-Reich, a remarkable individual whose dedication and passion changed the landscape of Type 1 Diabetes (T1D) in Canada
Susan’s journey began when her daughter, Amy, was diagnosed with T1D at a young age. Determined to make a difference, Susan, alongside four other families, embarked on a remarkable journey. They established the very first JDRF Chapter in Canada, located in Montreal, and commenced their tireless efforts to transform the landscape of T1D research. Working […]
Ross Chocolates is a proud supporter of diabetes research
Ross Chocolates, a longtime corporate partner of JDRF Canada is generously providing a matching gift in honour of National Diabetes Awareness Month. All donations made throughout November will be matched by Ross Chocolates, up to a maximum of $20,000. JDRF Canada sent their CEO Stefano Urbani some questions regarding the inspiration behind their support of […]
JDRF’s Legal Sector Challenge: Taking Bold Steps to Accelerate Type 1 Diabetes Research
When we come together as a collective, we can accomplish great things. A dedicated group of lawyers and law firms from across Canada rallied together this year to support JDRF’s Legal Sector Challenge, raising funds to help accelerate the pace of type 1 diabetes (T1D) research. Thanks to their bold commitment to the T1D community, […]
The Sun Life Ride to Defeat Diabetes was a great success!
One of Canada’s longest running and top fundraising events held Rides in Montréal, Toronto and Calgary, on October 5, 12 and 19, 2023 respectively, along with community ‘Ride Your Way’ rides taking place across the country this past month. For 38 years the Sun Life Ride to Defeat Diabetes for JDRF has been bringing together […]
Halloween Guide
For many families newly diagnosed with type 1 diabetes (T1D), Halloween can feel overwhelming – a holiday centered on candy when you’re just figuring out carb counting and nutrition. However, with the right tools and knowledge, Halloween can and should be just as fun for your child. Here are some helpful tips for having a […]
JDRF Golf Challenge a great success
Once again in 2023, David Garfinkle and Steven Mitchell – along with a team of supporters rallied Canadians to come together to support type 1 diabetes (T1D) research by committing to pick up their clubs this summer and join the JDRF Golf Challenge. The JDRF Golf Challenge has its roots in the JDRF Golf Marathon, first […]
New JDRF Canada and Stem Cell Network recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes
Dr. Sing-Young Chen is a postdoctoral researcher at the JDRF Centre of Excellence at the University of British Columbia, and the second annual recipient of a J. Andrew McKee Fellowship in Type 1 Diabetes (T1D), jointly funded by JDRF Canada and the Stem Cell Network (SCN) based at the JDRF Centre of Excellence at the […]
Results are out: TZIELD (teplizumab) benefits individuals newly diagnosed with type 1 diabetes
In a coordinated release of information today, Dr. Kevan Herold (Yale University) presented the PROTECT clinical trial results at the International Society for Paediatric and Adolescent Diabetes (ISPAD) conference simultaneous to the release of the published article in the New England Journal of Medicine, and a press release issued by Sanofi (who acquired Provention Bio in April 2023). […]
Building capacity for the future of type 1 diabetes research
Training the next generation of researchers and clinicians in type 1 diabetes (T1D) is a central goal of JDRF’s global research strategy. Support of these emerging leaders is essential to ensure continued momentum in T1D research, and to facilitate translation of today’s evidence into tomorrow’s improved treatments and cures. JDRF seeks to attract and retain […]